Concepedia

Leah Schutt

LS

Statistics

Publications

11

Citations

714

H-Index

11

Active since

2004

Affiliations

University of Guelph(Current)

Leah Schutt is an author at University of Guelph specializing in pharmacology, medicine, and molecular oncology.

Publications per year

2004–2021

11

Publications

11

Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton’s Tyrosine Kinase Inhibitor in Early Clinical Development

James J. Crawford, Adam R. Johnson, Dinah Misner et al. · Journal of Medicinal Chemistry · 2018 · 247 citations · Full text

, , +17

GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer

Jun Liang, Robert A. Blake, Jae H. Chang et al. · Journal of Medicinal Chemistry · 2021 · 135 citations · Full text

, , +15

Target arm affinities determine preclinical efficacy and safety of anti-HER2/CD3 bispecific antibody

Karin Staflin, Christina L. Zuch de Zafra, Leah Schutt et al. · JCI Insight · 2020 · 99 citations · Full text

, , +17

Antibody-Mediated Inhibition of Fibroblast Growth Factor 19 Results in Increased Bile Acids Synthesis and Ileal Malabsorption of Bile Acids in Cynomolgus Monkeys

Rama Pai, Dorothy French, Ning Ma et al. · Toxicological Sciences · 2012 · 76 citations · Full text

, , +17

Electrochemical Reduction of Hexahydro-1,3,5-trinitro-1,3,5-triazine in Aqueous Solutions

Pascale M. L. Bonin, Dorin Bejan, Leah Schutt et al. · Environmental Science & Technology · 2004 · 46 citations

, , +17

1–5 of 11